MedTrace Logo

Prevalence of Osteosarcopenic Obesity in Older Adults

NCT04288401 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 460

Last updated 2020-05-19

No results posted yet for this study

Summary

Osteosarcopenic Obesity (OSO) is a syndrome characterized by the loss of bone and muscle in addition to increase in the fat tissue as a result of aging process. It is the latest point of impairment in the bone,muscle and adipose tissue in older adults. OSO, as the name suggests, is the combination of three syndrome frequently encountered in the elderly: osteopenia/osteoporosis, sarcopenia and obesity. The aims of study are to determine the prevalence of OSO syndrome in community-dwelling adults of Turkey and determine the possible factors regarding risk of falling in this population

Conditions

Sponsors & Collaborators

  • Goztepe Training and Research Hospital

    collaborator OTHER

  • Istanbul Medeniyet University

    lead OTHER

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-02-25
Primary Completion
2020-03-31
Completion
2020-04-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04288401 on ClinicalTrials.gov